Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings

Authors

Tara Castellano, LSU Health Sciences Center - New OrleansFollow
Victoria Bae-Jump, University of North Carolina School of Medicine, Chapel Hill, NC
Angeles Alvarez Secord, Duke University, Durham, NC
Natalie Danziger, Foundation Medicine Incorporated, Cambridge, MA
Ryon Graf, Foundation Medicine Inc., San Diego, CA
Julia C. F. Quintanilha, Foundation Medicine Inc., San Diego, CA
Gerald Li, Foundation Medicine Inc., San Diego, CA
Brennan Decker, Foundation Medicine Inc., San Diego, CA
Douglas Lin, Foundation Medicine Inc., San Diego, CA
Julia Elvin, Foundation Medicine Inc., San Diego, CA
Bhavana Pothuri, New York University Langone, New York, NY

Document Type

Conference Proceeding

Publication Date

9-22-2023

Publication Title

Gynecologic Oncology

Abstract

Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer, March 25 - 28, 2023, Tampa, FL

First Page

S194

Last Page

S195

Volume

176

Issue

Supplement 1

Comments

Abstract Number 1320

Recommended Citation

Castellano, Tara; Bae-Jump, Victoria; Secord, Angeles Alvarez; Danziger, Natalie; Graf, Ryon; Quintanilha, Julia C. F.; Li, Gerald; Decker, Brennan; Lin, Douglas; Elvin, Julia; and Pothuri, Bhavana, "Liquid biopsy for advanced endometrial cancer: Prognostic value of plasma circulating DNA fraction in real-world settings" (2023). School of Medicine Faculty Publications. 2428.
https://digitalscholar.lsuhsc.edu/som_facpubs/2428
10.1016/j.ygyno.2023.06.221